Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-21-005773
Filing Date
2021-03-11
Accepted
2021-03-10 20:57:18
Documents
5
Effectiveness Date
2021-03-11

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 81364
2 ex5-1.htm EX-5.1 37757
3 ex23-1.htm EX-23.1 3973
4 ex5-1_01.jpg GRAPHIC 2712
5 ex5-1_02.jpg GRAPHIC 2224
  Complete submission text file 0001493152-21-005773.txt   131419
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254112 | Film No.: 21731525
SIC: 7389 Services-Business Services, NEC